MX2017007953A - Tratamiento de la degeneración de la retina mediante el uso de células progenitoras. - Google Patents

Tratamiento de la degeneración de la retina mediante el uso de células progenitoras.

Info

Publication number
MX2017007953A
MX2017007953A MX2017007953A MX2017007953A MX2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A MX 2017007953 A MX2017007953 A MX 2017007953A
Authority
MX
Mexico
Prior art keywords
cells
progenitor cells
treatment
retinal degeneration
retinal
Prior art date
Application number
MX2017007953A
Other languages
English (en)
Inventor
Harris Ian
Sophia DEJNEKA Nadine
Cao Jing
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MX2017007953A publication Critical patent/MX2017007953A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se divulgan métodos y composiciones para tratar y reducir degeneración retinal usando células progenitoras y medios condicionados de células progenitoras, tales como células derivadas posparto; también se divulgan factores tróficos y otros agentes secretados por las células, que protegen a las células retinales e inhiben la apoptosis de células retinales tales como células fotorreceptoras.
MX2017007953A 2014-12-16 2015-12-04 Tratamiento de la degeneración de la retina mediante el uso de células progenitoras. MX2017007953A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462092658P 2014-12-16 2014-12-16
US201562236732P 2015-10-02 2015-10-02
PCT/US2015/063931 WO2016099949A2 (en) 2014-12-16 2015-12-04 Treatment of retinal degeneration using progenitor cells

Publications (1)

Publication Number Publication Date
MX2017007953A true MX2017007953A (es) 2018-02-09

Family

ID=56110114

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007953A MX2017007953A (es) 2014-12-16 2015-12-04 Tratamiento de la degeneración de la retina mediante el uso de células progenitoras.

Country Status (15)

Country Link
US (1) US20160166619A1 (es)
EP (1) EP3233096A4 (es)
JP (1) JP2018500325A (es)
KR (1) KR20170094368A (es)
CN (1) CN107249608A (es)
AU (1) AU2015363088A1 (es)
BR (1) BR112017012581A2 (es)
CA (1) CA2970641A1 (es)
MX (1) MX2017007953A (es)
PH (1) PH12017501028A1 (es)
RU (1) RU2017124983A (es)
SG (1) SG11201704668PA (es)
TW (1) TW201632620A (es)
WO (1) WO2016099949A2 (es)
ZA (1) ZA201704793B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
AU2016365312A1 (en) * 2015-12-04 2018-05-24 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
JP6799248B2 (ja) * 2016-09-28 2020-12-16 澁谷工業株式会社 細胞シートの切断方法
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
CN109456937A (zh) * 2018-12-27 2019-03-12 广州赛莱拉干细胞科技股份有限公司 一种制备子宫内膜干细胞的培养基以及制备方法
US10758571B1 (en) 2019-04-09 2020-09-01 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
CN112156172B (zh) * 2020-10-26 2022-11-25 上海交通大学医学院附属第九人民医院 血小板反应蛋白1在制备预防和/或治疗年龄相关性黄斑变性的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2338982T3 (pl) * 2003-06-27 2016-01-29 Depuy Synthes Products Inc Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
US9572840B2 (en) * 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Also Published As

Publication number Publication date
WO2016099949A2 (en) 2016-06-23
CN107249608A (zh) 2017-10-13
SG11201704668PA (en) 2017-07-28
US20160166619A1 (en) 2016-06-16
EP3233096A2 (en) 2017-10-25
ZA201704793B (en) 2019-01-30
PH12017501028A1 (en) 2018-03-05
RU2017124983A (ru) 2019-01-17
KR20170094368A (ko) 2017-08-17
RU2017124983A3 (es) 2019-06-05
JP2018500325A (ja) 2018-01-11
AU2015363088A1 (en) 2017-06-15
BR112017012581A2 (pt) 2017-12-26
EP3233096A4 (en) 2018-08-22
CA2970641A1 (en) 2016-06-23
TW201632620A (zh) 2016-09-16

Similar Documents

Publication Publication Date Title
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
PH12017501028A1 (en) Treatment of retinal degeneration using progenitor cells
MY192927A (en) Fused bicyclic compounds for the treatment of disease
GB2541571A (en) Pharmaceutical compositions
AU2019268074A1 (en) Methods for treating hepcidin-mediated disorders
EP3800248A3 (en) Crispr-cas-related methods, compositions and components for cancer immunotherapy
EP3556858A3 (en) Crispr/cas-related methods and compositions for treating cystic fibrosis
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
MX2017008456A (es) Compuestos biciclicos fusionados para el tratamiento de enfermedades.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
IL251616B (en) Methods and compounds for the treatment and prevention of muscle mass loss
MX2018012902A (es) Composiciones y métodos para el tratamiento de trastornos de almacenamiento lisosomal y trastornos caracterizados por disfunción lisosomal.
MX2020004666A (es) Compuestos de pilocarpina con ácido lipoico para el tratamiento de trastornos oculares.
PH12017501864A1 (en) Compositions and methods for treating autism
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
ZA201703467B (en) Methods of treating ocular conditions
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
MX2017012342A (es) Compuestos biciclicos fusionados para el tratamiento de enfermedades,.
MX2019006552A (es) Terapia génica para mucopolisacaridosis de tipo i.
PH12017501022A1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
AU2016323967A8 (en) Compositions and methods for the treatment and prevention of radiation dermatitis
WO2018045078A3 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING LYMPHATIC SYSTEM DISORDERS